tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VTGN Stock Latest News

Vistagen Appoints Elissa Cote as Chief Development Officer
Company AnnouncementsVistagen Appoints Elissa Cote as Chief Development Officer
30d ago
8K
VTGN
Vistagen appoints Elissa Cote as Chief Corporate Development Officer
PremiumThe Fly
Vistagen appoints Elissa Cote as Chief Corporate Development Officer
1M ago
VTGN
Vistagen Therapeutics’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Vistagen Therapeutics’ Earnings Call Highlights Progress and Challenges
1M ago
VTGN
Vistagen Therapeutics Reports Progress in Clinical Trials
PremiumCompany Announcements
Vistagen Therapeutics Reports Progress in Clinical Trials
1M ago
VTGN
Closing Bell Movers: Futures extend decline amid Middle East tension
PremiumThe Fly
Closing Bell Movers: Futures extend decline amid Middle East tension
1M ago
LZB
ZTS
VistaGen Files Prospectus to Raise $175 Million
PremiumCompany AnnouncementsVistaGen Files Prospectus to Raise $175 Million
1M ago
8K
VTGN
Vistagen reports FY25 EPS ($1.67), two estimates ($1.74)
Premium
The Fly
Vistagen reports FY25 EPS ($1.67), two estimates ($1.74)
1M ago
VTGN
Options Volatility and Implied Earnings Moves Today, June 17, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, June 17, 2025
1M ago
JBL
LZB
Options Volatility and Implied Earnings Moves This Week, June 16 – June 20, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, June 16 – June 20, 2025
1M ago
KR
ACB
VTGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VTGN Earnings this Week: How Will it Perform?
1M ago
VTGN
VistaGen Announces Progress on PALISADE-3 Clinical Trial
PremiumCompany Announcements
VistaGen Announces Progress on PALISADE-3 Clinical Trial
2M ago
8K
VTGN
Vistagen provides update on timeline for ongoing trial in U.S. PALISADE program
PremiumThe Fly
Vistagen provides update on timeline for ongoing trial in U.S. PALISADE program
2M ago
VTGN
Positive Outlook on VistaGen Therapeutics Driven by Promising Clinical Developments and Solid Financial Position
PremiumRatingsPositive Outlook on VistaGen Therapeutics Driven by Promising Clinical Developments and Solid Financial Position
5M ago
VTGN
VistaGen’s Earnings Call: Progress and Challenges
Premium
Company Announcements
VistaGen’s Earnings Call: Progress and Challenges
5M ago
VTGN
Vistagen Reports Q3 Earnings and Pipeline Progress
Premium
Company Announcements
Vistagen Reports Q3 Earnings and Pipeline Progress
5M ago
VTGN
VistaGen Reports Q3 2025 Financial Results and Updates
PremiumCompany Announcements
VistaGen Reports Q3 2025 Financial Results and Updates
5M ago
8K
VTGN
Vistagen reports Q3 EPS (46c) vs (22c) last year
PremiumThe Fly
Vistagen reports Q3 EPS (46c) vs (22c) last year
5M ago
VTGN
Is VTGN a Buy, Before Earnings?
PremiumPre-Earnings
Is VTGN a Buy, Before Earnings?
5M ago
VTGN
Vistagen granted USPTO patent for AV-101 to treat neuropathic pain
PremiumThe Fly
Vistagen granted USPTO patent for AV-101 to treat neuropathic pain
6M ago
VTGN
Vistagen announces results from PH284 study in cancer cachexia
PremiumThe FlyVistagen announces results from PH284 study in cancer cachexia
6M ago
VTGN
Vistagen enrolls first patient in repeat dose study of fasedienol
Premium
The Fly
Vistagen enrolls first patient in repeat dose study of fasedienol
7M ago
VTGN
VistaGen Therapeutics Advances Neurocircuitry Treatments
Premium
Company Announcements
VistaGen Therapeutics Advances Neurocircuitry Treatments
8M ago
8K
VTGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >